Sopharma AD (BUL: SFA)
Bulgaria flag Bulgaria · Delayed Price · Currency is BGN
5.70
0.00 (0.00%)
At close: Dec 2, 2024

Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of BGN 944.66 million. The enterprise value is 1.34 billion.

Market Cap 944.66M
Enterprise Value 1.34B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date Jan 30, 2025
Ex-Dividend Date Nov 7, 2024

Share Statistics

Sopharma AD has 165.73 million shares outstanding. The number of shares has increased by 35.29% in one year.

Current Share Class n/a
Shares Outstanding 165.73M
Shares Change (YoY) +35.29%
Shares Change (QoQ) +4.23%
Owned by Insiders (%) 9.17%
Owned by Institutions (%) 4.89%
Float 40.65M

Valuation Ratios

The trailing PE ratio is 12.32.

PE Ratio 12.32
Forward PE n/a
PS Ratio 0.45
PB Ratio 1.19
P/TBV Ratio 1.30
P/FCF Ratio 8.51
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.57, with an EV/FCF ratio of 12.07.

EV / Earnings 16.35
EV / Sales 0.65
EV / EBITDA 8.57
EV / EBIT 13.11
EV / FCF 12.07

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.48.

Current Ratio 1.43
Quick Ratio 0.73
Debt / Equity 0.48
Debt / EBITDA 3.02
Debt / FCF 3.67
Interest Coverage 6.60

Financial Efficiency

Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 4.23%.

Return on Equity (ROE) 10.95%
Return on Assets (ROA) 3.35%
Return on Capital (ROIC) 4.23%
Revenue Per Employee 434,506
Profits Per Employee 17,350
Employee Count 4,721
Asset Turnover 1.36
Inventory Turnover 4.48

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.72% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -19.72%
50-Day Moving Average 5.83
200-Day Moving Average 5.98
Relative Strength Index (RSI) 46.95
Average Volume (20 Days) 4,842

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of BGN 2.05 billion and earned 81.91 million in profits. Earnings per share was 0.46.

Revenue 2.05B
Gross Profit 448.37M
Operating Income 80.85M
Pretax Income 95.97M
Net Income 81.91M
EBITDA 117.38M
EBIT 80.85M
Earnings Per Share (EPS) 0.46
Full Income Statement

Balance Sheet

The company has 38.10 million in cash and 407.24 million in debt, giving a net cash position of -369.14 million or -2.23 per share.

Cash & Cash Equivalents 38.10M
Total Debt 407.24M
Net Cash -369.14M
Net Cash Per Share -2.23
Equity (Book Value) 841.72M
Book Value Per Share 4.80
Working Capital 249.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 137.97 million and capital expenditures -26.98 million, giving a free cash flow of 110.99 million.

Operating Cash Flow 137.97M
Capital Expenditures -26.98M
Free Cash Flow 110.99M
FCF Per Share 0.67
Full Cash Flow Statement

Margins

Gross margin is 21.86%, with operating and profit margins of 3.94% and 3.99%.

Gross Margin 21.86%
Operating Margin 3.94%
Pretax Margin 4.68%
Profit Margin 3.99%
EBITDA Margin 5.72%
EBIT Margin 3.94%
FCF Margin 5.41%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 2.63%.

Dividend Per Share 0.15
Dividend Yield 2.63%
Dividend Growth (YoY) -89.00%
Years of Dividend Growth 2
Payout Ratio 278.20%
Buyback Yield -35.29%
Shareholder Yield -32.65%
Earnings Yield 8.12%
FCF Yield 11.75%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Sopharma AD has an Altman Z-Score of 3.09.

Altman Z-Score 3.09
Piotroski F-Score n/a